{
    "info": {
        "nct_id": "NCT06106828",
        "official_title": "A Phase III, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Moderate-to-Severe Thyroid Eye Disease",
        "inclusion_criteria": "- Clinical diagnosis of TED based on CAS\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Decrease in CAS or proptosis of >≥ 2 points or ≥ 2 mm, respectively, in the study eye between Screening and Study Baseline (Day 1)\n* Requiring immediate surgical ophthalmological intervention or planning corrective surgery or irradiation during the course of the study, in the judgment of the investigator\n* Identified pre-existing ophthalmic disease that, in the judgment of the investigator, would preclude study participation or complicate interpretation of study results, including corneal decompensation unresponsive to medical management and including ophthalmic diseases that will likely require prohibited therapy during the study\n* Any serious medical condition or abnormality in clinical laboratory tests that, in the investigator's judgment, precludes an individual's safe participation in and completion of the study\n* Pregnant or breastfeeding, or intention of becoming pregnant during the study or within 3 months after the final dose of satralizumab",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "- Clinical diagnosis of TED based on CAS",
            "criterions": [
                {
                    "exact_snippets": "Clinical diagnosis of TED",
                    "criterion": "TED (Thyroid Eye Disease)",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "based on CAS",
                    "criterion": "CAS (Clinical Activity Score)",
                    "requirements": [
                        {
                            "requirement_type": "basis for diagnosis",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Any serious medical condition or abnormality in clinical laboratory tests that, in the investigator's judgment, precludes an individual's safe participation in and completion of the study",
            "criterions": [
                {
                    "exact_snippets": "Any serious medical condition ... precludes an individual's safe participation in and completion of the study",
                    "criterion": "serious medical condition",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "abnormality in clinical laboratory tests ... precludes an individual's safe participation in and completion of the study",
                    "criterion": "abnormality in clinical laboratory tests",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Requiring immediate surgical ophthalmological intervention or planning corrective surgery or irradiation during the course of the study, in the judgment of the investigator",
            "criterions": [
                {
                    "exact_snippets": "Requiring immediate surgical ophthalmological intervention",
                    "criterion": "need for immediate surgical ophthalmological intervention",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "planning corrective surgery or irradiation during the course of the study",
                    "criterion": "planned corrective surgery or irradiation during the course of the study",
                    "requirements": [
                        {
                            "requirement_type": "planned",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Identified pre-existing ophthalmic disease that, in the judgment of the investigator, would preclude study participation or complicate interpretation of study results, including corneal decompensation unresponsive to medical management and including ophthalmic diseases that will likely require prohibited therapy during the study",
            "criterions": [
                {
                    "exact_snippets": "Identified pre-existing ophthalmic disease that, in the judgment of the investigator, would preclude study participation or complicate interpretation of study results",
                    "criterion": "pre-existing ophthalmic disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "impact on study participation or interpretation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "corneal decompensation unresponsive to medical management",
                    "criterion": "corneal decompensation",
                    "requirements": [
                        {
                            "requirement_type": "responsiveness to medical management",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "ophthalmic diseases that will likely require prohibited therapy during the study",
                    "criterion": "ophthalmic diseases requiring prohibited therapy",
                    "requirements": [
                        {
                            "requirement_type": "likelihood of requiring prohibited therapy during the study",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pregnant or breastfeeding, or intention of becoming pregnant during the study or within 3 months after the final dose of satralizumab",
            "criterions": [
                {
                    "exact_snippets": "Pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "intention of becoming pregnant during the study or within 3 months after the final dose of satralizumab",
                    "criterion": "intention to become pregnant",
                    "requirements": [
                        {
                            "requirement_type": "timeframe",
                            "expected_value": [
                                "during the study",
                                "within 3 months after the final dose of satralizumab"
                            ]
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "line": "* Decrease in CAS or proptosis of >≥ 2 points or ≥ 2 mm, respectively, in the study eye between Screening and Study Baseline (Day 1)",
            "criterions": [
                {
                    "exact_snippets": "Decrease in CAS ... of >≥ 2 points ... in the study eye between Screening and Study Baseline (Day 1)",
                    "criterion": "CAS (Clinical Activity Score) in the study eye",
                    "requirements": [
                        {
                            "requirement_type": "change",
                            "expected_value": {
                                "operator": "<=",
                                "value": -2,
                                "unit": "points"
                            }
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": [
                                "between Screening and Study Baseline (Day 1)"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "Decrease in ... proptosis of ≥ 2 mm ... in the study eye between Screening and Study Baseline (Day 1)",
                    "criterion": "proptosis in the study eye",
                    "requirements": [
                        {
                            "requirement_type": "change",
                            "expected_value": {
                                "operator": "<=",
                                "value": -2,
                                "unit": "mm"
                            }
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": [
                                "between Screening and Study Baseline (Day 1)"
                            ]
                        }
                    ]
                }
            ]
        }
    ],
    "failed_miscellaneous": []
}